glp-1 and prostate cancer Could medications help slow progression?⁣ ⁣ A new Cleveland Clinic study found those taking GLP-1s were less likely to develop stage IV disease in several cancer types, when compared to GLP-1 Agonists: Dual Benefits for

Description

We think that is particularly important in prostate cancer because the volume of fat that sits around the prostate is very clearly linked with poorer drug response in patients and a faster disease progression and spread outside of the prostate. GLP1 drugs are considered very effective but can cause a predictable cluster of gastrointestinal effects and a smaller set of more serious, less common risks that need watching. Medicare currently covers GLP1 drugs (like Ozempic, Mounjaro, and sometimes Wegovy/Zepbound) only when they are used for approved medical indications such as type 2 diabetes or cardiovascular risk reduction not for weight loss alone

S., Jullienne, A., Rosselin, G., & Garel, J

Algunos de los medicamentos para la prdida de peso ms populares (y caros) podran pronto estar cubiertos por Medicare y Medicaid, al menos para algunas personas, bajo un nuevo experimento

At Blackhawk Hair Restoration, our team is experienced in teasing apart normal, temporary shedding from true progressive hair lossand in designing a treatment plan that respects both your health goals and your appearance